A Phase 1b Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SR419

Clinical trial NCT04494815 · COMPLETED

Trial details

NCT number: NCT04494815
Sponsor: Shanghai SIMR Biotechnology Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Peripheral Neuropathic Pain

Start date: 2020-09-18
Primary completion: 2022-05-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.